Endogenous sodium-potassium-chloride cotransport inhibitor in congestive heart failure
- 15 November 1996
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 28 (6) , 1464-1470
- https://doi.org/10.1016/s0735-1097(96)00339-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Purification and Chemical Characterization of a Potent Inhibitor of the Na-K-Cl Cotransport System in Rat UrineBiochemical and Biophysical Research Communications, 1996
- Evidence for a bufodienolide Na/K pump inhibitor in human urine.American Journal of Hypertension, 1996
- Na,K-ATPase Inhibitors from Bovine Hypothalamus and Human Plasma Are Different from Ouabain: Nanogram Scale CD Structural AnalysisBiochemistry, 1995
- Inhibition of Na-K-Cl cotransport fluxes and salidiuretic action by an urinary extract of salt-loaded ratsPflügers Archiv - European Journal of Physiology, 1994
- Biologic and physical characteristics of the non-peptidic, non-digitalis-like natriuretic hormoneKidney International, 1993
- Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.Circulation, 1991
- Mass spectral characterization of an endogenous digitalislike factor from human plasma.Hypertension, 1991
- Plasma concentrations of atrial natriuretic peptide in patients with artificial and transplanted heartsEuropean Journal of Clinical Pharmacology, 1988
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986